M.V.I. PEDIATRIC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover M.v.i. Pediatric, and when can generic versions of M.v.i. Pediatric launch?
M.v.i. Pediatric is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in M.V.I. PEDIATRIC is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; phytonadione; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. There are six drug master file entries for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; phytonadione; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e profile page.
Summary for M.V.I. PEDIATRIC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for M.V.I. PEDIATRIC |
What excipients (inactive ingredients) are in M.V.I. PEDIATRIC? | M.V.I. PEDIATRIC excipients list |
DailyMed Link: | M.V.I. PEDIATRIC at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for M.V.I. PEDIATRIC
US Patents and Regulatory Information for M.V.I. PEDIATRIC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | M.V.I. PEDIATRIC | ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; phytonadione; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e | FOR SOLUTION;INTRAVENOUS | 018920-001 | Sep 21, 2000 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |